Thomas R. Kreil from Takeda Austria presented at London Calling 2024. The session title was “Pathogen safety in biopharma: sequencing to come.” Kreil began by noting that they do not want to detect viruses in biopharmaceuticals. For this, they use Adventitious Agent Testing (AAT): they search for cytopathic effects on cells. However, current methods are […]
Tetyana Vasylyeva from the University of California, Irvine, presented at London Calling 2024. The topic was “Informing infectious disease interventions with genomics during big events.” I was curious about the big events! This session was part of the Clinical & Biopharma Day on Friday, May 24, 2024. Vasylyeva studies phylogenetics, phylodynamics, and phylogeography of HIV! […]
The London Calling 2024 session I watched tonight was titled “Long-read sequencing for pathogenic and novel variation discovery in rare diseases.” Ahmad Abou Tayoun from the Al Jailila Children’s Specialty Hospital in the United Arab Emirates was the presenter. This session was part of the Clinical & Biopharma Day on Friday, May 24, 2024. They spoke about […]
The London Calling 2024 session I watched tonight is called “Precision immunology in transplant: paving the way to operational tolerance.” Karen Sherwood from The University of British Columbia presented the Genome Canada Transplant Consortium work. The group noticed that trying to match organs and recipients on a genetic level was complex. Using next-generation sequencing, HLA […]
Tonight I watched the London Calling session on “Rapid nephrogenomics for thrombotic microangiopathies.” Laurent Mesnard from Sorbonne University in France was the presenter. They defined thrombotic microangiopathies (TMA) as a group of rare diseases with similar manifestations. Early diagnosis of TMA is essential. It currently takes about three days to screen. The Regulator of Complement […]
Jose-Crispin Zavala Alvarado works at PathoQuest in France. They gave a presentation at London Calling 2024. The topic was “iDTECT Integration Site Analysis assay: a paradigm shift for the quality control of biologics in rare diseases.” This collaboration between PathoQuest and Oxford Nanopore was highly productive. It resulted in the launch of the first ONT-driven […]
Tonight, I watched Jessica Anderson, a Senior Field Applications Scientist with Oxford Nanopore Technologies (ONT), present at London Calling 2024. The session was part of the Masterclass 2024 series. It was titled “How to select the right library prep workflow for your experiment.” This session started with an introduction describing how nanopore sensing works. Anderson explained that during […]
We start the Portable Genome Sequencing course tomorrow! I wanted to review the latest Oxford Nanopore Technologies (ONT) recommendations for extracting DNA and RNA. The London Calling 2024 session “How to extract high-quality DNA and RNA” was the one I watched tonight. Vania Costa, a Field Applications Scientist with ONT, presented this ONT Masterclass. This […]
Tonight, I watched the London Calling 2024 session on Nanopore’s origins. The session was a panel with attendees and presenters in person and online. Dave Deamer was one person I was able to meet in person this summer. Dave Deamer spoke from the University of California, Santa Cruz, about the origins of life and nanopore […]
As we prepare for the start of a new semester, I decided to watch a Masterclass from London Calling 2024. Akelia Wauchope-Odumbo, Associate Director Technical Applications—Americas with Oxford Nanopore Technologies, presented on experimental design. The session title was “How to get started with nanopore sequencing and plan your experiment.” The masterclass series guides users from “sample to […]